Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.78 - $8.9 $1.19 Million - $13.6 Million
-1,524,309 Closed
0 $0
Q2 2022

Aug 12, 2022

SELL
$0.69 - $1.21 $1.83 Million - $3.2 Million
-2,645,832 Reduced 63.45%
1,524,309 $1.47 Million
Q1 2022

May 12, 2022

SELL
$1.02 - $3.8 $63,369 - $236,082
-62,127 Reduced 1.47%
4,170,141 $4.96 Million
Q4 2021

Feb 10, 2022

SELL
$3.26 - $4.66 $395,777 - $565,742
-121,404 Reduced 2.79%
4,232,268 $13.8 Million
Q3 2021

Nov 09, 2021

SELL
$4.08 - $5.66 $447,510 - $620,811
-109,684 Reduced 2.46%
4,353,672 $19.5 Million
Q2 2021

Aug 11, 2021

BUY
$5.01 - $7.48 $22.4 Million - $33.4 Million
4,463,356 New
4,463,356 $24.3 Million

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.